DUBLIN, Nov. 13, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering.
In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study.
In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth.
Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Global Insulin Market Overview to 2018
4. Industry Trends and Drivers
5. Key Market Restraints
6. Global Insulin Delivery Devices Market Outlook to 2018
7. Insulin Delivery Devices: Current and Future Outlook to 2018
8. Emerging Devices
9. Key Players
- Abbott Laboratories
- B. Braun Melsungen AG
- Becton Dickinson
- Eli Lilly
- F. Hoffmann La Roche
- Insulet Corporation
- Johnson and Johnson
- Novo Nordisk
- Ypsomed Holding AG
For more information visit http://www.researchandmarkets.com/research/wld6dd/global_insulin
Media Contact: Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets